Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ganyushu Granules
- Development stage
- Unknown
- Lead developer
- Hefei Jingfang Pharmaceutical Technology Development
- Administration
- Oral
01
Overview
Ganyushu Granules is a Traditional Chinese Medicine (TCM) preparation developed by Hefei Jingfang Pharmaceutical Technology Development Co., Ltd. for the treatment of premenstrual syndrome (PMS). It is specifically formulated for patients presenting with the TCM pattern of "Liver Qi Stagnation" (肝郁气滞证). The drug is designed to soothe the liver and regulate qi, addressing symptoms such as emotional instability, breast tenderness, and abdominal distension commonly associated with PMS. It has been evaluated in multi-center, randomized, double-blind, dose-parallel clinical trials to establish its safety and efficacy profile and to determine optimal dosing for further clinical development.
- Brand names
- Ganyushu Granules
- Other names
- Ganyushu Keli肝郁舒颗粒
02
Targets
BCL-2 (BCL-2 family)ALDH1A1 (Aldehyde dehydrogenase 1 family member A1)CASP9 (Caspase-9)ADH (Alcohol dehydrogenase family)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)CASP8 (Caspase-8)CASP3 (Caspase-3)IL1B (Interleukin-1 beta)
Beyond the preview
Go deeper on Ganyushu Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ganyushu Granules.